Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Adelson

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Obstetrics and Gynecology|May 1, 1992
Endometrial adenocarcinoma without prior hormone replacement in a diabetic patient with gonadal dysgenesisK Kratzert-Adams, M D Adelson, S Z Badawy, et al.
Cancer|March 1, 1991
Structural and functional integrity of ovarian tumor tissue obtained by ultrasonic aspirationM A Thompson, M D Adelson, M A Jozefczyk, et al.
Obstetrics and Gynecology|July 1, 1988
Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspiratorM D Adelson, M S Baggish, D B Seifer, et al.
American Journal of Clinical Oncology|August 1, 1990
Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, V V Baker, et al.
Cancer Research|November 15, 1988
Aromatization of testosterone by epithelial tumor cells cultured from patients with ovarian carcinomaM A Thompson, M D Adelson, L M Kaufman, et al.
Gynecologic Oncology|January 1, 1987
Cervical carcinoma DNA content, S-fraction, and malignancy grading. I. InterrelationshipsT S Johnson, M D Adelson, N Sneige, et al.
Gynecologic Oncology|September 30, 1999
Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group studyJ S Berek, M Markman, B Stonebraker, et al.
Gynecologic Oncology|January 1, 1987
Cervical carcinoma DNA content, S-fraction, and malignancy grading. II. Comparison with clinical stagingM D Adelson, T S Johnson, N Sneige, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology GroupJ T Thigpen, M F Brady, R D Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicitiesD R Gandara, W A Nahhas, M D Adelson, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Obstetrics and Gynecology|May 1, 1992
Endometrial adenocarcinoma without prior hormone replacement in a diabetic patient with gonadal dysgenesisK Kratzert-Adams, M D Adelson, S Z Badawy, et al.
Cancer|March 1, 1991
Structural and functional integrity of ovarian tumor tissue obtained by ultrasonic aspirationM A Thompson, M D Adelson, M A Jozefczyk, et al.
Obstetrics and Gynecology|July 1, 1988
Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspiratorM D Adelson, M S Baggish, D B Seifer, et al.
American Journal of Clinical Oncology|August 1, 1990
Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, V V Baker, et al.
Cancer Research|November 15, 1988
Aromatization of testosterone by epithelial tumor cells cultured from patients with ovarian carcinomaM A Thompson, M D Adelson, L M Kaufman, et al.
Gynecologic Oncology|January 1, 1987
Cervical carcinoma DNA content, S-fraction, and malignancy grading. I. InterrelationshipsT S Johnson, M D Adelson, N Sneige, et al.
Gynecologic Oncology|September 30, 1999
Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group studyJ S Berek, M Markman, B Stonebraker, et al.
Gynecologic Oncology|January 1, 1987
Cervical carcinoma DNA content, S-fraction, and malignancy grading. II. Comparison with clinical stagingM D Adelson, T S Johnson, N Sneige, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology GroupJ T Thigpen, M F Brady, R D Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicitiesD R Gandara, W A Nahhas, M D Adelson, et al.
Pageof 4